Sankyo Co., Ltd. provided consolidated earnings guidance for the year ending March 31, 2023. For the year, the company expects net sales of JPY 135,000 million, operating profit of JPY 45,000 million, profit attributable to owners of parent JPY 35,000 million and basic earnings per share of JPY 602.71.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,666 JPY | +0.97% | +1.22% | +1.30% |
Apr. 08 | AstraZeneca hails neurological data for Ultomiris, Soliris | AN |
Apr. 08 | AstraZeneca's, Daiichi's Enhertu receives US FDA approval | AN |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.30% | 2.34B | |
-22.80% | 729M | |
+10.02% | 697M | |
+30.97% | 366M | |
+6.57% | 340M | |
+2.97% | 340M | |
-8.40% | 272M | |
+17.74% | 185M | |
+26.93% | 98.85M | |
-28.98% | 62.77M |
- Stock Market
- Equities
- 6417 Stock
- News Sankyo Co., Ltd.
- Sankyo Co., Ltd. Provides Consolidated Earnings Guidance for the Year Ending March 31, 2023